A Quantitative Intersectionality Analysis of HIV/STI Prevention and Healthcare Access Among Transgender and Nonbinary People
Authors:
- Diana M. TordoffDTDiana M. Tordoff
- the Seattle Trans and Non-binary Sexual Health (STARS) Advisory BoardTBthe Seattle Trans and Non-binary Sexual Health (STARS) Advisory Board
- 26 September 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Epidemiology
- Vol. 34 (6) , 827-837
Abstract
Background: Transgender and nonbinary people experience substantial barriers to accessing healthcare, including prevention of HIV and other sexually transmitted infections (HIV/STI), due to structural inequities. We examined differences in insurance, HIV/STI prevalence, testing, and preexposure prophylaxis use among transgender and nonbinary people living in Washington State by race and ethnicity and gender. Methods: We pooled data from five 2019–2021 Washington State HIV/STI surveillance data sources to obtain a large and diverse sample of 1648 transgender and nonbinary participants. We calculated the risk difference (RD) for each outcome and used Poisson regression to estimate a surrogate measure of additive interaction—attributable proportion (AP)—that measures the proportion of the excess prevalence of the outcome observed at the intersection of gendered and racialized experience, beyond that expected from gender or race and ethnicity alone. Results: Participants reported overall high levels of poverty (29% incomes <$15,000 and 7% unstable housing). Certain groups, especially racial/ethnic minority transgender women, were disproportionately impacted by HIV/STIs (RDs from 20% to 43% and APs from 50% to 85%) and less likely to currently have insurance (RDs from 25% to 39% and APs from 74% to 93%) than that expected based on gendered or racialized experience alone. Conclusions: Our findings highlight the heterogeneity in insurance access, HIV/STI positivity, and prevention utilization within transgender communities. We observed that a large proportion of increased HIV/STI prevalence among racial/ethnic minority transgender women was attributable to the intersection of gender and race and ethnicity. Our findings highlight the importance of trans-inclusive models of HIV/STI prevention that address multilevel barriers rooted in cissexism and structural racism.Keywords
This publication has 50 references indexed in Scilit:
- Discrimination and Delayed Health Care Among Transgender Women and MenMedical Care, 2016
- Racial and Ethnic Differences in Experiences of Discrimination in Accessing Health Services Among Transgender People in the United StatesInternational Journal of Transgenderism, 2015
- Attributing Effects to InteractionsEpidemiology, 2014
- Racial Health Disparities in a Cohort of 5,135 Transgender VeteransJournal of Racial and Ethnic Health Disparities, 2014
- Incorporating intersectionality theory into population health research methodology: Challenges and the potential to advance health equitySocial Science & Medicine, 2014
- HIV treatment cascade among transgender women in a San Francisco respondent driven sampling studySexually Transmitted Infections, 2014
- Gender Affirmation: A Framework for Conceptualizing Risk Behavior Among Transgender Women of ColorSex Roles, 2012
- The Problem With the Phrase Women and Minorities: Intersectionality—an Important Theoretical Framework for Public HealthAmerican Journal of Public Health, 2012
- “I Don't Think This Is Theoretical; This Is Our Lives”: How Erasure Impacts Health Care for Transgender PeopleJournal of the Association of Nurses in AIDS Care, 2009
- The Complexity of IntersectionalitySigns: Journal of Women in Culture and Society, 2005